Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

FULC

Fulcrum Therapeutics (FULC.Q) announced positive results today from its ongoing Phase 1 trial with FTX-6058 in healthy adult volunteers. “We are very pleased with the interim results from this…